Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Steve Jobs Product Development: Apple’s Art Levinson Talks About Steve Jobs, Product Development

Page 1 of 2

Steve JobsSteve Jobs Product Development: For many people, those on the outside looking in, not much has changed at Apple Inc. (NASDAQ:AAPL) since the passing of Steve Jobs. While current CEO Tim Cook has done an admirable job leading the company, many recall their time spent with Jobs.

One such guy is Arthur D. Levinson, a member of Apple’s board of directors since 2000. Not only did Levinson work alongside Jobs at Apple Inc. (NASDAQ:AAPL), but the two became close personal friends over the years.

In a recent piece published by, Levinson had this to say:

“I’m still not to the point where I walk into that boardroom and don’t miss Steve. He was a one of a kind guy … The Steve Jobs that was in the public eye was not, for the most part, the Steve Jobs that I knew.”

These quotes were pulled from Levinson’s interview Tuesday afternoon at Stanford’s Graduate School of Business

Levinson took questions from the audience, primarily students of the university. In addition to his own past, he talked about Steve Jobs as well as the future of Apple Inc. (NASDAQ:AAPL).

When the time came to talk about the Cupertino-based company’s long term forecast, here is what he had to say:

“There [are] long-term signs of how a company is doing and whether or not Apple sells 47 or 48 million iPhones — let somebody else worry about that.”

While there were a lot of points brought up during the interview session, details surrounding new products may have been the most interesting.

Many would  believe that Levinson, along with the other directors, would have a lot to say about product development. He shot this notion down, however.

Here is what the Forbes article had to say:

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!